These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32904597)
1. Gold Nanoclusters as an Antibacterial Alternative Against Yang H; Cai R; Zhang Y; Chen Y; Gu B Int J Nanomedicine; 2020; 15():6401-6408. PubMed ID: 32904597 [TBL] [Abstract][Full Text] [Related]
2. Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells. Chen C; Doll NK; Casadei G; Bremner JB; Lewis K; Kelso MJ Bioorg Med Chem Lett; 2014 Jan; 24(2):595-600. PubMed ID: 24360560 [TBL] [Abstract][Full Text] [Related]
4. Gold Nanoclusters-Decorated Zeolitic Imidazolate Frameworks with Reactive Oxygen Species Generation for Photoenhanced Antibacterial Study. Hui S; Liu Q; Huang Z; Yang J; Liu Y; Jiang S Bioconjug Chem; 2020 Oct; 31(10):2439-2445. PubMed ID: 33040528 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Locher HH; Seiler P; Chen X; Schroeder S; Pfaff P; Enderlin M; Klenk A; Fournier E; Hubschwerlen C; Ritz D; Kelly CP; Keck W Antimicrob Agents Chemother; 2014; 58(2):892-900. PubMed ID: 24277020 [TBL] [Abstract][Full Text] [Related]
7. The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity. Kang JK; Hwang JS; Nam HJ; Ahn KJ; Seok H; Kim SK; Yun EY; Pothoulakis C; Lamont JT; Kim H Antimicrob Agents Chemother; 2011 Oct; 55(10):4850-7. PubMed ID: 21807975 [TBL] [Abstract][Full Text] [Related]
8. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR mBio; 2015 Mar; 6(2):. PubMed ID: 25805733 [TBL] [Abstract][Full Text] [Related]
9. A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile. Katzianer DS; Yano T; Rubin H; Zhu J Int J Antimicrob Agents; 2014 Jul; 44(1):69-73. PubMed ID: 24837414 [TBL] [Abstract][Full Text] [Related]
10. Bacteria producing antimicrobials against Clostridium difficile isolated from human stool. Khattab RA; Ahmed NA; Ragab YM; Rasmy SA Anaerobe; 2020 Jun; 63():102206. PubMed ID: 32339663 [TBL] [Abstract][Full Text] [Related]
11. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study. Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676 [TBL] [Abstract][Full Text] [Related]
12. Ultrapotent Inhibitor of Naclerio GA; Abutaleb NS; Li D; Seleem MN; Sintim HO J Med Chem; 2020 Oct; 63(20):11934-11944. PubMed ID: 32960605 [No Abstract] [Full Text] [Related]
13. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835 [TBL] [Abstract][Full Text] [Related]
14. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence. Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467 [TBL] [Abstract][Full Text] [Related]
15. Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing. Marreddy RKR; Olaitan AO; May JN; Dong M; Hurdle JG Microbiol Spectr; 2021 Oct; 9(2):e0044821. PubMed ID: 34468187 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Guanidinylate Polycarbonates Show Oral In Vivo Efficacy Against Clostridioides Difficile. Xue M; Chakraborty S; Gao R; Wang S; Gu M; Shen N; Wei L; Cao C; Sun X; Cai J Adv Healthc Mater; 2024 Jun; 13(14):e2303295. PubMed ID: 38321619 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Colonization Resistance Against Clostridioides difficile. Pike CM; Theriot CM J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile. Kumar M; Mathur T; Barman TK; Ramkumar G; Bhati A; Shukla G; Kalia V; Pandya M; Raj VS; Upadhyay DJ; Vaishnavi C; Chakrabarti A; Das B; Bhatnagar PK Antimicrob Agents Chemother; 2012 Nov; 56(11):5986-9. PubMed ID: 22869573 [TBL] [Abstract][Full Text] [Related]